{"id":"W2337335671","doi":"10.1200/jco.2012.30.15_suppl.539","title":"BOLERO-2: Health-related quality-of-life in metastatic breast cancer patients treated with everolimus and exemestane versus exemestane.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Exemestane; Internal medicine; Breast cancer; Aromatase inhibitor; Quality of life (healthcare); Placebo; Everolimus; Hazard ratio; Oncology; Clinical endpoint; Interim analysis; Proportional hazards model; Cancer; Randomized controlled trial; Confidence interval; Aromatase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002638623,0.0008933013,0.002115889,0.0004756423,0.0002228129,0.0008114073,0.0008687281,0.000645596,0.006792736],"category_scores_gemma":[0.001630421,0.0003972809,0.002383941,0.0003645736,0.0006102898,0.0005698511,0.000655753,0.001851961,0.0004805205],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001074697,"about_ca_system_score_gemma":0.0009093358,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007653882,"about_ca_topic_score_gemma":0.002628521,"domain_scores_codex":[0.9991584,0.0005218961,0.00004585687,0.00009448372,0.00008613413,0.00009327311],"domain_scores_gemma":[0.9992049,0.0002010883,0.0002984229,0.00003253265,0.00002979246,0.0002333348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9591201,0.006235122,0.003268349,0.0008776623,0.001872894,0.00001977769,0.00004651547,0.0009545478,0.003598755,0.00007592894,0.0008565325,0.02307377],"study_design_scores_gemma":[0.7358345,0.2254764,0.03049716,0.0001714906,0.002511332,0.0001093729,0.00004320997,0.001428829,0.001608629,0.000165159,0.002112723,0.00004115166],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9809257,0.01214242,0.0003572633,0.0005084051,0.0001798416,0.001496822,0.001887027,0.00005409555,0.002448427],"genre_scores_gemma":[0.9854788,0.003342291,0.001919906,0.0006495028,0.0001687957,0.00309181,0.002605421,0.00001862889,0.002724791],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006792736,"threshold_uncertainty_score":0.02272391,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2181384238488936,"score_gpt":0.5185650640622901,"score_spread":0.3004266402133965,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}